Name: NMRA Balance Sheet - Neumora Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

NMRA - Neumora Therapeutics, Inc.

USD | NASDAQ | Healthcare

NMRA Balance Sheet - Neumora Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21
Cash And Short Term Investments
Cash And Equivalents	147.1	182.5	129.1	124.5	126.9	142.1	275.7	150.7	182.9	374.0	412.3	204.2	210.9	240.9	252.5	-	-
Restricted Cash	147.1	-	129.1	124.5	128.1	1.2	276.9	151.9	184.1	-	413.5	205.4	212.1	0.1	253.8	-	-	-
Short Term Investments	-	-	42.5	93.1	122.5	165.4	65.6	221.0	239.8	79.9	97.3	-	-	130.9	-	-	-
Cash And Short Term Investments	147.1	182.5	171.5	217.6	249.4	307.6	341.3	371.6	422.7	454.0	509.6	204.2	210.9	371.9	252.5
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	5.1	3.4	0.5	0.6	1.1	3.3	6.1	1.1	1.5	0.3	2.2	-	-	7.1	-
Non-Current Liabilities
Long Term Debt	53.0	54.5	19.6	19.5	-	0.0	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.0	-	-
Supplementary Data
Total Debt	113.0	54.5	39.6	39.5	-	0.0	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Cash And Short Term Investments
Cash And Equivalents	182.5	142.1	374.0	240.9	-
Restricted Cash	182.5	143.4	375.3	242.2	-
Short Term Investments	-	165.4	79.9	130.9	-
Cash And Short Term Investments	182.5	307.6	454.0	371.9	-
Receivables
Accounts Receivable	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	8.0	5.3	24.3	16.0	-
Other Current Assets	-	-
Non-Current Assets
Property, Plant & Equipment Gross	0.2	3.2	3.2	3.0	-
Accumulated Depreciation	0.2	2.0	1.4	1.1	-
Property,Plant & Equipment Net	0.0
Current Liabilities
Accounts Payable	3.4	3.3	0.3	7.1	-
Short Term Debt	60.0	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	54.5	-	-	-	-
Operating Lease Liabilities Non-Current	0.2	-	1.9	5.1	-
Deferred Revenue Non-Current	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	(1,184.1)	(947.2)
Supplementary Data
Total Debt	114.5	-	-	-	-
Net debt	(68.0)	-	-	-	-
Working Capital	158.1	284.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)